THE SYSTEMIC OXIDATIVE STRESS AS A SURROGATE OF CORONARY ATHEROSCLEROTIC PLAQUE INSTABILITY AND RUPTURE PREDICTOR
Keywords:acute coronary syndrome (ACS), chronic coronary syndrome (CCS), oxidative stress, free oxygen radical test (FORT), free oxygen radicals defense test (FORD), REDOX index, oxidative stress profile, vulnerable plaque, plaque rupture
Background. Oxidative stress is crucial in developing broad spectrum of diseases, including atherosclerosis and related life-threatening conditions, such as acute coronary syndrome (ACS) mainly caused by atherosclerotic plaque vulnerability.
Objective. To clarify the relation between oxidative stress and plaque instability we decided to compare oxidative profiles of patients with acute coronary syndrome (ACS) and with chronic coronary syndrome (CCS), evaluated at admission to the coronary care unit (CCU) of LTD Clinic-LJ (Kutaisi, Georgia) in April 2018 - June 2019, who underwent successful primary percutaneous coronary intervention (PCI).
Methods. 191 patients were enrolled (100 patients with ACS in Group 1 and 91 patients with CCS in Group 2) into the study. Using the CR3000 FORM PLUS (Callegari Srl, Catellani Group, Italy) – Callegari Point of Care instrument we evaluated free oxygen radical test (FORT), free oxygen radicals defense (FORD), calculated REDOX Index and the overall Profile of oxidative stress.
Results. The mean/median concentration of Free Oxygen Radicals was significantly higher in the patients with ACS (404.37±9.83 Fort units/2.36 mmol/l H2O2 eq. vs 282.34±9.83 Fort units/2.36 mmol/l H2O2 eq., p<0.0001). Significant correlation was found between advanced oxidative stress and acute coronary syndrome (OR 14.42 95% CI (7.08-29.4), RR 3.26 95% CI (2.31-4.60) with high diagnostic characteristics (sensitivity of 82% and specificity of 92.3%; positive predictive value of 92% and positive likelihood ratio of 11).
Conclusion. Oxidative stress is crucial in life-threatening acute coronary events. Measurement of overall oxidative stress profile, as a surrogate of plaque instability and rupture predictor, could help the clinicians in risk stratification and prevention of acute coronary syndrome (ACS).
Global Health Observatory (GHO) data. World Health Organization 2018. https://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/.
Zègre-Hemsey JK, Asafu-Adjei J, Fernandez A, Brice J. Characteristics of prehospital electrocardiogram use in north carolina using a novel linkage of emergency medical services and emergency department data. Prehospital Emergency Care. 2019 Nov 2;23(6):772-9.
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R. Concept of vulnerable/unstable plaque. Arteriosclerosis, thrombosis, and vascular biology. 2010 Jul 1;30(7):1282-92.
Lafont A. Basic aspects of plaque vulnerability. Heart. 2003 Oct 1;89(10):1262-7.
Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. New England Journal of Medicine. 1984 May 3;310(18):1137-40.
Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, thrombosis, and vascular biology. 2000 May;20(5):1262-75.
Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS. Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther. 2011; 9:1315–30.
Redgrave JN, Gallagher P, Lovett JK, Rothwell PM. Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke. 2008; 39:1722–9.
Pelisek J, Eckstein H-H, Zernecke A. Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke. Arch Immunol Ther Exp (Warsz). 2012; 60:431–42.
Saba L, Potters F, van der Lugt A, Mallarini G. Imaging of the fbrous cap in atherosclerotic carotid plaque. Cardiovasc Intervent Radiol. 2010; 33:681–9.
Marnane M, Prendeville S, McDonnell C, Noone I, Barry M, Crowe M, et al. Plaque infammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis. Stroke. 2014; 45:801–6.
Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. Journal of Thrombosis and Haemostasis. 2005 Feb;3(2):254-67.
Mury P, Chirico EN, Mura M, Millon A, Canet-Soulas E, Pialoux V. Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity. Sports Med. 2018;48(12):2725-41.
Shao B and Heinecke JW: HDL, lipid peroxidation, and atherosclerosis. J Lipid Res 50:599-601, 2009.
Valko M, Rhodes C, Moncol J, Izakovic MM, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-biological interactions. 2006 Mar 10;160(1):1-40.
Bastani A, Rajabi S, Daliran A, Saadat H, Karimi-Busheri F. Oxidant and antioxidant status in coronary artery disease. Biomedical reports. 2018 Oct 1;9(4):327-32.
Channon KM. Oxidative stress and coronary plaque stability. Arterioscler Thromb Vasc Biol. 2002;22(11):1751-2.
Pavlatou MG, Papastamataki M, Apostolakou F, Papassotiriou I, Tentolouris N. FORT and FORD: Two Simple and Rapid Assays in the Evaluation of Oxidative Stress in Patients with Type 2 Diabetes Mellitus. Metabolism 2009 Nov;58(11):1657-62.
Garelnabi MO, Brown WV, Le NA. Evaluation of a novel colorimetric assay for free oxygen radicals as marker of oxidative stress. Clinical biochemistry. 2008 Oct 1;41(14-15):1250-4.
Lorgis l, Zeller M, Dentan G, Sicard P, Richard C, Buffet P, L’Huillier I, Beer J C, Cottin Y, Rochette R, Vergely C. The Free Oxygen Radicals Test (FORT) to Assess Circulating Oxidative Stress in Patients with Acute Myocardial Infarction. Atherosclerosis. 2010 Dec;213(2):616-21.
Park S-Y, Lee S-P. The Relationship between Oxidative Stress and Oxidative Markers. Korean J Clin Lab Sci 2014,46:31-7.
Lewis NA, Newell J, Burden R, Howatson G, Pedlar CR. Critical Difference and Biological Variation in Biomarkers of Oxidative Stress and Nutritional Status in Athletes. PLoS One. 2016;11(3):e0149927.
How to Cite
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).